Sitemap
April 12, 2014 Articles
Filter by Available Specialty
- Alberta research fund aims to advance diabetes discoveries
- Brain metastases in melanoma require multidisciplinary approach
- FDA grants breakthrough therapy designation for Mydicar
- Interferon-free triple regimen plus ribavirin effective in previously untreated patients
- Orthofix announces new chairman of the board
- PD-L1 expression predicted response to immunotherapy in melanoma
- PD-L1 expression predicted response to immunotherapy in melanoma
- T-VEC superior to GM-CSF for unresected, metastatic melanoma
- T-VEC superior to GM-CSF for unresected, metastatic melanoma
- Vismodegib effective in basal cell carcinoma
- Vismodegib effective in basal cell carcinoma